| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kairos Pharma, LTD. | Chief Financial Officer | COMMON STOCK | 60.8K | $91.2K | $1.50 | Nov 22, 2024 | Direct |
| GENELUX Corp | Vice President, Finance | Stock Option (right to buy) | 40K | Sep 11, 2023 | Direct | ||
| Sacks Parente Golf, Inc. | Chief Financial Officer | Options to Purchase Common Stock | 36K | Sep 9, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| KAPA | Kairos Pharma, LTD. | Nov 22, 2024 | 1 | $3.75K | 4 | Nov 25, 2024 | Chief Financial Officer |
| KAPA | Kairos Pharma, LTD. | Sep 16, 2024 | 0 | $0 | 3 | Sep 24, 2024 | Chief Financial Officer |
| SPGC | Sacks Parente Golf, Inc. | Sep 9, 2024 | 1 | $0 | 4 | Sep 12, 2024 | Chief Financial Officer |
| SPGC | Sacks Parente Golf, Inc. | Sep 9, 2024 | 0 | $0 | 3 | Sep 12, 2024 | Chief Financial Officer |
| GNLX | GENELUX Corp | Sep 11, 2023 | 1 | $0 | 4 | Sep 12, 2023 | Vice President, Finance |
| GNLX | GENELUX Corp | Aug 18, 2023 | 1 | -$30.8K | 4 | Aug 22, 2023 | Chief Financial Officer |
| GNLX | GENELUX CORP | Feb 17, 2023 | 1 | $0 | 4 | May 2, 2023 | Chief Financial Officer |
| GNLX | GENELUX CORP | Jan 25, 2023 | 0 | $0 | 3 | Jan 25, 2023 | Chief Financial Officer |